100 years of revenue, guranteed for BionTech

For all the retards who think that the pandemic is over and time to dump the vaccine stocks as they will make no revenue, its time for a history lesson. Sanofi and GSK make $10B a year on a flu pandemic that happened 100 years ago (1918 spanish flu). Covid is not over, the variants are still on the rise. We need boosters forever. The current vaccine makers, specially the mRNA tech based ones are going to make money for the years to follow, I bet for the next century. Out of two mRNA vaccine makers, Moderna ($MRNA) and BionTech ($BNTX), my personal bet is on BionTech, ​ The insiders didn’t sell a single share Vs Moderna sold around $2B worth. The CEO, Prof Uğur Şahin is a Professor, oncologist and immunologist, he currently owns 17% of the company, He and his wife, Dr. Özlem Türeci who is also a scientist and physician run the company, she doesn’t own a single share, but in for the science. vs Moderna CEO Stéphane Bancel is a harvard MBA. BNTX make more money than MRNA even after splitting profits from Pfizer. current EPS $34 vs $16. Current market cap of Biontech is $39B vs $69B for Moderna. Both got corrected 60% from the ATH in the past two months. Both have Flu + Covid vaccine boosters in the pipeline, capturing market share from Sanofi and GSK. BNTX have their own manufacturing sites as well as their big daddy Pfizer. Vs moderna contracts out to Swiss company Lonza ( whose share price rose to 50% in past year). Currently, BNTX only has FDA approval and emergency use authorizations across all age groups 5years+ >. They have approval and supply in over 126 countries. Every soul is a potential customer. They will have a different pricing for their boosters after the pandemic is over. BNTX has bigdaddy Pfizer backing, they both are working on Flu and shingles vaccine together with less than a 100 day turnover development time (mRNA tech folks) BNTX has 26 other pipelines (https://biontech.de/science/pipeline) The current price is 60% discount from its ATH. My position 2000 shares in IRA $200 Leap calls 01/20/23 Expiry $280 Calls 02/18/2022 Expiry ​ P.S anti-vaxers can fuck themselves, they get very vocal but they are a minority of 10-20% of population around the globe.

back

100 years of revenue, guranteed for BionTech

bullish

For all the retards who think that the pandemic is over and time to dump the vaccine stocks as they will make no revenue, its time for a history lesson. Sanofi and GSK make $10B a year on a flu pandemic that happened 100 years ago (1918 spanish flu). Covid is not over, the variants are still on the rise. We need boosters forever. The current vaccine makers, specially the mRNA tech based ones are going to make money for the years to follow, I bet for the next century. Out of two mRNA vaccine makers, Moderna ($MRNA) and BionTech ($BNTX), my personal bet is on BionTech,

  • The insiders didn't sell a single share Vs Moderna sold around $2B worth.
  • The CEO, Prof Uğur Şahin is a Professor, oncologist and immunologist, he currently owns 17% of the company, He and his wife, Dr. Özlem Türeci who is also a scientist and physician run the company, she doesn't own a single share, but in for the science. vs Moderna CEO Stéphane Bancel is a harvard MBA.
  • BNTX make more money than MRNA even after splitting profits from Pfizer.
  • current EPS $34 vs $16. Current market cap of Biontech is $39B vs $69B for Moderna. Both got corrected 60% from the ATH in the past two months.
  • Both have Flu + Covid vaccine boosters in the pipeline, capturing market share from Sanofi and GSK.
  • BNTX have their own manufacturing sites as well as their big daddy Pfizer. Vs moderna contracts out to Swiss company Lonza ( whose share price rose to 50% in past year).
  • Currently, BNTX only has FDA approval and emergency use authorizations across all age groups 5years+ >. They have approval and supply in over 126 countries. Every soul is a potential customer.
  • They will have a different pricing for their boosters after the pandemic is over.
  • BNTX has bigdaddy Pfizer backing, they both are working on Flu and shingles vaccine together with less than a 100 day turnover development time (mRNA tech folks)
  • BNTX has 26 other pipelines (https://biontech.de/science/pipeline)
  • The current price is 60% discount from its ATH.

My position

2000 shares in IRA

$200 Leap calls 01/20/23 Expiry

$280 Calls 02/18/2022 Expiry

P.S anti-vaxers can fuck themselves, they get very vocal but they are a minority of 10-20% of population around the globe.

read-time
1 min
200.00
Target Price
7/ 10
Confidence
6-12 Months
Timeframe
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC
Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

Access the latest tools and discussion channels with an account

reddit-sentiment

Reddit Sentiment
Analysis

portfolio-balancer

Portfolio Balancer
with brokerages

sec-dashboard

SEC Dashboard
with NLP

*/}aiodd-ad
next